Alder BioPharmaceuticals to Host Conference Call to Discuss Third Quarter 2016 Financial and Operating Results
October 20, 2016 08:00 ET
|
Alder BioPharmaceuticals, Inc.
BOTHELL, Wash., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today...
Signal Bay Completes Purchase of Portland Cannabis Testing Lab
October 20, 2016 08:00 ET
|
Signal Bay Inc.
Portland, Oregon , Oct. 20, 2016 (GLOBE NEWSWIRE) -- Signal Bay, Inc. (OTC PINK: SGBY) the market leader in cannabis testing and laboratory services announced today the completion of the...
Omnitek Engineering Receives Contract to Develop Euro 6 Heavy-Duty 13-Liter Natural Gas Engine
October 20, 2016 08:00 ET
|
Omnitek Engineering Corp.
VISTA, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Omnitek Engineering Corp. (OTCQB:OMTK) today announced it has signed a contract with a European customer to develop a heavy-duty 13-liter...
Valeritas to Release Third Quarter 2016 Financial Results and Host Conference Call on Thursday, November 10, 2016
October 20, 2016 08:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that the Company will release its third quarter 2016 financial results on Thursday,...
Seacoast Commerce Banc Holdings Announces Third Quarter 2016 Results
October 20, 2016 08:00 ET
|
Seacoast Commerce Banc Holdings
SAN DIEGO, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Seacoast Commerce Banc Holdings (OTC Pink:SCBH) (“Company”), and its wholly owned subsidiary Seacoast Commerce Bank (“Bank”), today announced its...
InvisibleShield Introduces Glass+ Screen Protection for Pixel and Pixel XL, Phones by Google
October 20, 2016 08:00 ET
|
ZAGG Inc
SALT LAKE CITY, Oct. 20, 2016 (GLOBE NEWSWIRE) -- InvisibleShield®, the leading global brand and innovator in screen protection, today announced InvisibleShield Glass+ for the Pixel and Pixel XL,...
CymaBay Therapeutics Announces that MBX-8025 has Received European Medicines Agency PRIority MEdicines (PRIME) Designation for the Treatment of Primary Biliary Cholangitis
October 20, 2016 08:00 ET
|
CymaBay Therapeutics, Inc.
NEWARK, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases...
Selecta Biosciences Presented Preclinical Data Applying SVP-Rapamycin in Gene Therapy at Annual Congress of the European Society of Gene and Cell Therapy
October 20, 2016 08:00 ET
|
Selecta Biosciences Inc
Data underscore potential of SVP-Rapamycin to enhance therapeutic benefit of gene therapies by mitigating unwanted humoral (antibody) and cellular immune responses WATERTOWN, Mass., Oct. 20, 2016 ...
Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) Meeting
October 20, 2016 08:00 ET
|
Adverum Biotechnologies, Inc.
MENLO PARK, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a gene therapy company committed to discovering and developing novel medicines for patients...
Semtech LoRa Wireless RF Technology Featured in New South Pacific Region IoT Network
October 20, 2016 08:00 ET
|
Semtech Corporation
CAMARILLO, Calif., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of analog and mixed-signal semiconductors, today announced its LoRa® devices and Wireless...
- October 21, 2024 02:00 ET JDE Peet’s appoints Rafael Oliveira as Chief Executive Officer
- October 21, 2024 01:30 ET ONWARD® Medical Announces Changes to Board of Directors, Including Addition of Medtech Leader Rob ten Hoedt as Incoming Chairman